188 related articles for article (PubMed ID: 18069905)
1. Momordica charantia (bitter melon). Monograph.
Altern Med Rev; 2007 Dec; 12(4):360-3. PubMed ID: 18069905
[No Abstract] [Full Text] [Related]
2. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
Shih CC; Lin CH; Lin WL; Wu JB
J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
[TBL] [Abstract][Full Text] [Related]
3. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.
Leung L; Birtwhistle R; Kotecha J; Hannah S; Cuthbertson S
Br J Nutr; 2009 Dec; 102(12):1703-8. PubMed ID: 19825210
[TBL] [Abstract][Full Text] [Related]
4. The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats.
Senanayake GV; Maruyama M; Shibuya K; Sakono M; Fukuda N; Morishita T; Yukizaki C; Kawano M; Ohta H
J Ethnopharmacol; 2004 Apr; 91(2-3):257-62. PubMed ID: 15120448
[TBL] [Abstract][Full Text] [Related]
5. Bitter melon (Momordica charantia): a review of efficacy and safety.
Basch E; Gabardi S; Ulbricht C
Am J Health Syst Pharm; 2003 Feb; 60(4):356-9. PubMed ID: 12625217
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
[TBL] [Abstract][Full Text] [Related]
7. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
Raina K; Kumar D; Agarwal R
Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
[TBL] [Abstract][Full Text] [Related]
8. Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
Inayat-ur-Rahman ; Malik SA; Bashir M; Khan R; Iqbal M
Phytomedicine; 2009 May; 16(5):401-5. PubMed ID: 19362455
[TBL] [Abstract][Full Text] [Related]
9. Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.
Krawinkel MB; Keding GB
Nutr Rev; 2006 Jul; 64(7 Pt 1):331-7. PubMed ID: 16910221
[TBL] [Abstract][Full Text] [Related]
10. Does bitter melon contain an activator of AMP-activated kinase?
McCarty MF
Med Hypotheses; 2004; 63(2):340-3. PubMed ID: 15236800
[TBL] [Abstract][Full Text] [Related]
11. A case of atrial fibrillation due to Momordica charantia (bitter melon).
Erden I; Ordu S; Erden EC; Caglar SO
Ann Saudi Med; 2010; 30(1):86-7. PubMed ID: 20103967
[No Abstract] [Full Text] [Related]
12. Emerging Antitumor Activities of the Bitter Melon (Momordica charantia).
Fang EF; Froetscher L; Scheibye-Knudsen M; Bohr VA; Wong JH; Ng TB
Curr Protein Pept Sci; 2019; 20(3):296-301. PubMed ID: 29932035
[TBL] [Abstract][Full Text] [Related]
13. The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial.
Soo May L; Sanip Z; Ahmed Shokri A; Abdul Kadir A; Md Lazin MR
Complement Ther Clin Pract; 2018 Aug; 32():181-186. PubMed ID: 30057048
[TBL] [Abstract][Full Text] [Related]
14. Antiulcer activity of methanolic extract of Momordica charantia L. in rats.
Alam S; Asad M; Asdaq SM; Prasad VS
J Ethnopharmacol; 2009 Jun; 123(3):464-9. PubMed ID: 19501279
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: a case study for adaptation.
Yaldız G; Sekeroglu N; Kulak M; Demirkol G
Nat Prod Res; 2015; 29(6):543-5. PubMed ID: 25141891
[TBL] [Abstract][Full Text] [Related]
16. Extraction, fractionation and characterization of bitter melon seed proteins.
Horax R; Hettiarachchy N; Over K; Chen P; Gbur E
J Agric Food Chem; 2010 Feb; 58(3):1892-7. PubMed ID: 20052973
[TBL] [Abstract][Full Text] [Related]
17. Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management.
Snee LS; Nerurkar VR; Dooley DA; Efird JT; Shovic AC; Nerurkar PV
Nutr J; 2011 Jul; 10():78. PubMed ID: 21794176
[TBL] [Abstract][Full Text] [Related]
18. The secret garden.
Gelo F; Harris R
Fam Med; 2009 Jun; 41(6):391-2. PubMed ID: 19492183
[No Abstract] [Full Text] [Related]
19. Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats.
Shetty AK; Kumar GS; Sambaiah K; Salimath PV
Plant Foods Hum Nutr; 2005 Sep; 60(3):109-12. PubMed ID: 16187012
[TBL] [Abstract][Full Text] [Related]
20. Emerging Trends On Drug Delivery Strategy of Momordica charantia against Diabetes and its Complications.
Thent ZC; Das S; Zaidun NH
Curr Drug Deliv; 2018; 15(4):453-460. PubMed ID: 28545355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
